These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6264256)

  • 1. Hyperactivity following injection of a glutamate agonist and 6,7-ADTN into rat nucleus accumbens and its inhibition by THIP.
    Arnt J
    Life Sci; 1981 Apr; 28(14):1597-603. PubMed ID: 6264256
    [No Abstract]   [Full Text] [Related]  

  • 2. A lesioning and 2-deoxyglucose study of the hyperactivity produced by an intra-accumbens dopamine agonist.
    Patel S; Slater P; Crossman AR
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):334-40. PubMed ID: 4094623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of intrapallidal drugs on hyperactivity induced by nucleus accumbens dopamine receptor stimulation.
    Slater P; Longman DA; Dickinson SL
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):201-6. PubMed ID: 7155200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of neurotensin and [D-Tyr11]-NT on the hyperactivity induced by intra-accumbens administration of a potent dopamine receptor agonist.
    Jolicoeur FB; Rivest R; St-Pierre S; Gagné MA; Dumais M
    Neuropeptides; 1985 Apr; 6(2):143-56. PubMed ID: 2987745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of GABA compounds injected into the subpallidal regions of rat brain on nucleus accumbens evoked hyperactivity.
    Patel S; Slater P
    Behav Neurosci; 1988 Aug; 102(4):596-600. PubMed ID: 2844207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of locomotor activity by intra-accumbens AMPA is not inhibited by neonatal 6-hydroxydopamine-induced lesions.
    Boldry RC; Layer RT; Wallace LJ; Uretsky NJ
    Neurosci Lett; 1992 Apr; 138(2):265-9. PubMed ID: 1376874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA.
    Boldry RC; Willins DL; Wallace LJ; Uretsky NJ
    Brain Res; 1991 Sep; 559(1):100-8. PubMed ID: 1685936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following alpha-methyltyrosine or reserpine.
    Wachtel H; Ahlenius S; Andén NE
    Psychopharmacology (Berl); 1979 Jun; 63(3):203-6. PubMed ID: 113804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of reserpine on dopamine metabolite in the nucleus accumbens and locomotor activity in freely moving rats.
    Sugita R; Sawa Y; Nomura S; Zorn SH; Yamauchi T
    Neurochem Res; 1989 Mar; 14(3):267-70. PubMed ID: 2725828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens.
    Boldry RC; Kelland MD; Engber TM; Chase TN
    Brain Res; 1993 Jan; 600(2):331-4. PubMed ID: 7679606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralin.
    Horn AS; Kaptein B; Mulder TB; de Vries JB; Wynberg H
    J Med Chem; 1984 Oct; 27(10):1340-3. PubMed ID: 6090664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action.
    Costall B; Domeney AM; Naylor RJ
    Psychopharmacology (Berl); 1984; 82(3):174-80. PubMed ID: 6144126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J
    Eur J Pharmacol; 1983 May; 90(1):47-55. PubMed ID: 6135618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantia innominata: critical link in the behavioral expression of mesolimbic dopamine stimulation in the rat.
    Swerdlow NR; Swanson LW; Koob GF
    Neurosci Lett; 1984 Sep; 50(1-3):19-24. PubMed ID: 6493625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK; Jackson DM
    Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscimol a GABA-agonist injected into the nucleus accumbens increases apomorphine stereotypy and decreases the motility.
    Scheel-Krũger J; Cools AR; van Wel PM
    Life Sci; 1977 Dec; 21(11):1697-702. PubMed ID: 563960
    [No Abstract]   [Full Text] [Related]  

  • 18. Nucleus accumbens lesions reduce amphetamine hyperthermia but not hyperactivity.
    Wirtshafter D; Asin KE; Kent EW
    Eur J Pharmacol; 1978 Oct; 51(4):449-52. PubMed ID: 710513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low doses of accumbens dopamine modulate amygdala suppression of spontaneous exploratory activity in rats.
    Yim CY; Mogenson GJ
    Brain Res; 1989 Jan; 477(1-2):202-10. PubMed ID: 2649208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microinjection of 8-OH-DPAT into nucleus accumbens attenuates naloxone-induced morphine withdrawal syndrome.
    Dzoljic MR; v Ent M; Kaplan CD; Saxena PR
    Prog Clin Biol Res; 1990; 328():441-4. PubMed ID: 2137629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.